A Novel Drinkable Food Supplement Formulation Reduces Hair Shedding and Increases the Percentage of Anagen Scalp Hair Follicles in Females with Hair Loss

    November 2025 in “ Journal of Clinical Medicine
    Manuel Sáez Moya, Gillian E. Westgate, Ralf Paus, Daniela Grohmann
    TLDR The drinkable supplement reduced hair shedding and increased hair growth in women.
    This study evaluated a novel drinkable food supplement's efficacy in reducing hair shedding and increasing hair density in 37 women with telogen effluvium (TE). Over 6 months, participants experienced a 12% increase in hair density and a 28% reduction in hair shedding, with significant improvements in the anagen to catagen/telogen (A:C/T) ratio. Self-perception surveys showed high satisfaction with hair improvements. While results are promising, further research with a larger, placebo-controlled trial is needed to confirm these findings and explore the supplement's effects on the hair growth cycle.
    Discuss this study in the Community →

    Research cited in this study

    40 / 40 results

    Related Community Posts Join

    6 / 625 results

    Similar Research

    6 / 1000+ results
      Hair Disorders

      research Hair Disorders

      November 2019 in “Harper's Textbook of Pediatric Dermatology”
      Understanding normal hair growth and loss in children is key to diagnosing and treating hair disorders.
      Hair Loss in Hospital Medicine: A Practical Guide

      research Hair Loss in Hospital Medicine: A Practical Guide

      3 citations , July 2012 in “British journal of hospital medicine”
      The guide helps clinicians diagnose and manage hair loss, detailing examination techniques and treatments for different types of alopecia.
      Proceedings of the Ninth World Congress for Hair Research 2015

      research Proceedings of the Ninth World Congress for Hair Research 2015

      January 2017 in “Journal of Investigative Dermatology Symposium Proceedings”
      The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.